Correlation Between Mereo BioPharma and Annovis Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Annovis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Annovis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Annovis Bio, you can compare the effects of market volatilities on Mereo BioPharma and Annovis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Annovis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Annovis Bio.

Diversification Opportunities for Mereo BioPharma and Annovis Bio

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Mereo and Annovis is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Annovis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annovis Bio and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Annovis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annovis Bio has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Annovis Bio go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Annovis Bio

Given the investment horizon of 90 days Mereo BioPharma is expected to generate 7.61 times less return on investment than Annovis Bio. But when comparing it to its historical volatility, Mereo BioPharma Group is 2.81 times less risky than Annovis Bio. It trades about 0.01 of its potential returns per unit of risk. Annovis Bio is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  906.00  in Annovis Bio on September 1, 2024 and sell it today you would lose (235.00) from holding Annovis Bio or give up 25.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Annovis Bio

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Annovis Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Mereo BioPharma and Annovis Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Annovis Bio

The main advantage of trading using opposite Mereo BioPharma and Annovis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Annovis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will offset losses from the drop in Annovis Bio's long position.
The idea behind Mereo BioPharma Group and Annovis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years